MedPath

海南赞邦制药有限公司

Ownership
-
Established
1988-10-12
Employees
-
Market Cap
-
Website
www.zambon.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Glipizide Tablets

Product Name
美吡达
Approval Number
国药准字H20054586
Approval Date
Jul 30, 2024
NMPA

Nimesulide Granules

Product Name
尼美舒利颗粒
Approval Number
国药准字H20020604
Approval Date
Jul 30, 2024
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20013254
Approval Date
Jul 30, 2024
NMPA

Acetylcysteine Tablets

Product Name
乙酰半胱氨酸片
Approval Number
国药准字H20080325
Approval Date
May 26, 2022
NMPA

Acetylcysteine Tablets

Product Name
乙酰半胱氨酸片
Approval Number
国药准字H20080326
Approval Date
May 26, 2022
NMPA

Ibuprofen Arginine Tablets

Product Name
精氨酸布洛芬片
Approval Number
国药准字H20110028
Approval Date
Jan 11, 2021
NMPA

Ibuprofen Arginine Tablets

Product Name
精氨酸布洛芬片
Approval Number
国药准字H20110027
Approval Date
Nov 17, 2020
NMPA

Acetylcysteine Granules

Product Name
富露施
Approval Number
国药准字H20000471
Approval Date
Apr 30, 2020
NMPA

Acetylcysteine Granules

Product Name
富露施
Approval Number
国药准字H20000472
Approval Date
Apr 30, 2020
NMPA

Glipizide Tablets

Product Name
美吡达
Approval Number
国药准字H10930076
Approval Date
Apr 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.